Edith C.
- Country
- France
- Department
- oncology
Research Overview
- Phase II Randomized Study of FOLFIRI Plus Zimberelimab and Domvanalimab Versus FOLFIRI in Patients With Second-Line Metastatic Gastro-Enteropancreatic or Unknown Origin Neuroendocrine Carcinoma
- Comparison of Intra-Arterial vs. Intravenous Oxaliplatin with LV5FU2 ± Irinotecan in First-Line Treatment of Liver-Restricted Metastatic Colorectal Cancer
- Evaluation of Circulating Tumor DNA-Guided Adjuvant Therapy with Fluorouracil, Folinic Acid, and Oxaliplatin in Stage II Colon Carcinoma
Data & Insights
Has run more than one trial at 94 of 229 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in the treatment of colorectal adenocarcinoma and colon carcinoma, with particular emphasis on advanced stages of these diseases.
- Colorectal Cancer Treatment
- Advanced Unresectable Disease Management
- Stage II Colon Cancer
Their research encompasses both early-stage and advanced colorectal malignancies, focusing on innovative treatment approaches.
Precision Medicine
The investigator focuses on targeted therapy approaches, particularly in the context of specific genetic mutations such as KRAS G12C in colorectal cancer.
- Molecular Targeted Therapies
- Genetic Mutation Analysis
- Personalized Treatment Strategies
Their work integrates molecular profiling with therapeutic decision-making in gastrointestinal oncology.
Biomarker Research
The investigator explores the clinical utility of circulating tumor DNA as a biomarker for treatment decision-making in colon cancer management.
- Liquid Biopsy Applications
- Treatment Response Monitoring
- Adjuvant Therapy Selection
Their research evaluates novel biomarker-based approaches for optimizing patient care in colorectal cancer.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.